Swiss pharmaceutical company Roche announced its agreement to acquire LumiraDx’s...
Japanese pharmaceutical company Otsuka Pharmaceutical has entered into a signifi...
Gilead Sciences has concluded a significant transaction with Compugen, securing ...
Pivotal bioVenture Partners has successfully concluded its second fund, securing...
The ongoing surge of interest in antibody-drug conjugates (ADCs) remains unabate...
In less than a week following the submission of the historic first request for a...
Sanofi, a prominent figure in the pharmaceutical realm, finds itself grappling w...
In a milestone announcement, the U.S. Food and Drug Administration (FDA) has gra...
Ionis Pharmaceuticals and AstraZeneca are capping off the year with a notable ac...
AbbVie has entered into an agreement to purchase Cerevel Therapeutics for $8.7 b...
Jazz Pharmaceuticals recently released the top-line findings from Phase II trial...
The timeline for the Multidisciplinary Association for Psychedelic Studies (MAPS...
CARsgen Therapeutics, a Chinese biotech company, is facing a significant setback...
A probe conducted by the British Medical Journal (BMJ) has provided insight into...
In a major move, the Novo Nordisk Foundation is allocating $260 million to pione...
Checkpoint Therapeutics, headquartered in Waltham, Massachusetts, recently encou...
